Described herein are pharmaceutical packaging systems which avert oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-delicate drugs, this kind of methods which include a syringe using an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with very reduced permeability to oxygen and